Elevated Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Elevated Financial Group's ABBV Position: Q3 2026 in Review
Elevated Financial Group reduced its AbbVie (ABBV) stake by 1.6% in Q3 2026, selling an estimated $5.9K and leaving 1,438 shares worth $376K. The position accounts for 0.11% of the portfolio, ranked #91.
Elevated Financial Group first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,278 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Elevated Financial Group held 1,438 shares of AbbVie worth $376K as of Q3 2026.
- Elevated Financial Group sold 23 AbbVie shares in Q3 2026, an estimated $5.9K.
- AbbVie made up 0.11% of Elevated Financial Group's portfolio in Q3 2026, its #91 holding.
- Elevated Financial Group first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,278 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Elevated Financial Group's 13F filing for Q3 2026, filed 16 Oct 2026.